Research Output per year
Fingerprint Dive into the research topics where Atul Bedi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 3 Similar Profiles
Apoptosis
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Medicine & Life Sciences
Phosphotransferases
Medicine & Life Sciences
Tumors
Chemical Compounds
Cell Death
Medicine & Life Sciences
DNA Damage
Medicine & Life Sciences
Death Domain Receptors
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1993 2019
Immune profiles in primary squamous cell carcinoma of the head and neck
Saloura, V., Izumchenko, E., Zuo, Z., Bao, R., Korzinkin, M., Ozerov, I., Zhavoronkov, A., Sidransky, D., Bedi, A., Hoque, M. O., Koeppen, H., Keck, M. K., Khattri, A., London, N., Kotlov, N., Fatima, A., Vougiouklakis, T., Nakamura, Y., Lingen, M., Agrawal, N. & 5 others, , Sep 1 2019, In : Oral Oncology. 96, p. 77-88 12 p.Research output: Contribution to journal › Article
Neoplasms
Regulatory T-Lymphocytes
Mutation
Macrophages
Carcinoma, squamous cell of head and neck
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
Ravi, R., Noonan, K., Pham, V., Bedi, R., Zhavoronkov, A., Ozerov, I. V., Makarev, E., Artemov, A. V., Wysocki, P. T., Mehra, R., Nimmagadda, S., Marchionni, L., Sidransky, D., Borrello, I. M., Izumchenko, E. & Bedi, A., Dec 1 2018, In : Nature Communications. 9, 1, 741.Research output: Contribution to journal › Article
Transforming Growth Factors
CTLA-4 Antigen
antibodies
Immunotherapy
cancer
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors
Izumchenko, E., Paz, K., Ciznadija, D., Sloma, I., Katz, A., Vasquez-Dunddel, D., Ben-Zvi, I., Stebbing, J., McGuire, W., Harris, W., Maki, R., Gaya, A., Bedi, A., Zacharoulis, S., Ravi, R., Wexler, L. H., Hoque, M., Rodriguez-Galindo, C., Pass, H., Peled, N. & 4 others, , 2017, In : Annals of Oncology. 28, 10, p. 2595-2605 11 p.Research output: Contribution to journal › Article
Heterografts
Neoplasms
Therapeutics
Exome
Translational Medical Research
SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells
Ozawa, H., Ranaweera, R. S., Izumchenko, E., Makarev, E., Zhavoronkov, A., Fertig, E., Howard, J. D., Markovic, A., Bedi, A., Ravi, R., Perez, J., Le, Q. T., Kong, C. S., Jordan, R. C., Wang, H., Kang, H., Quon, H., Sidransky, D. & Chung, C. H., Sep 1 2017, In : Clinical Cancer Research. 23, 17, p. 5162-5175 14 p.Research output: Contribution to journal › Article
Head and Neck Neoplasms
Gene Knockdown Techniques
Phenotype
Cell Line
Cetuximab
Patient-derived xenografts as tools in pharmaceutical development
Izumchenko, E., Meir, J., Bedi, A., Wysocki, P. T., Hoque, M. & Sidransky, D., 2016, (Accepted/In press) In : Clinical Pharmacology and Therapeutics.Research output: Contribution to journal › Article
Heterografts
Pharmaceutical Preparations
Neoplasms
Decision Making
Therapeutics